Back to BlackRock, Inc. BlackRock, Inc.

MBXMBX
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in MBX Biosciences, Inc.

BlackRock, Inc. holds 3.3M shares of MBX (MBX Biosciences, Inc.), worth $183.5M as of 2026-Q2. The position was increased (+13.0% shares). MBX represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$183.5M

Current Shares

3.3M

Total Value Change

+$170.1M

Total Shares Change

+2.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.3M
+13.0%
$183.5M0.0%$55.20
34
2026-Q1
Increased
2.9M
+0.7%
$87.8M0.0%$30.54
30
2025-Q4
Increased
2.9M
+49.2%
$92.1M0.0%$30.90
41
2025-Q3
Increased
2M
+93.5%
$34.3M0.0%$17.94
46
2025-Q2
Increased
1M
+29.2%
$11.5M0.0%$10.75
35
2025-Q1
Increased
783,042
+7.6%
$5.8M0.0%$7.76
29
2024-Q4
New
727,952
-
$13.4M0.0%$17.91
39

Other major holders of MBX: FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Polar Capital Holdings Plc

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used